Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 May 10;53:102331. doi: 10.1016/j.redox.2022.102331

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 The Authors

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

PMC Copyright notice

Fig. 3 — CBS is upregulated in human ovarian cancer and correlates with worse clinical prognosis. A) Immunohistochemical staining of a tissue microarray of epithelial ovarian cancer samples. Representative images are shown of none (i), weak (ii), moderate (iii), and (iv) strong staining. The panel was redrawn from data presented in Ref. [7]. B) CBS overexpression in the late stages and grades of ovarian cancer. The panel was redrawn from data presented in Ref. [7]. C) Survival curve showing the impact of CBS expression in ovarian cancer on overall survival from Atlas database (https://www.proteinatlas.org). The panel was redrawn from data presented in Ref. [61]. D) Survival curve showing the impact of CBS expression in ovarian serous cystic adenocarcinoma on overall survival from OV dataset. ∗p < 0.05 reflects higher survival rate in low-CBS-expressor patients. The panel was redrawn from data presented in Ref. [55].